Matt Hoffman

Kevin Maki, PhD, discussed the current state of lipid care in the United States.

Andrew R. Waxler, MD, FACC, discussed the Corus CAD test, which allows cardiologists to rule out multiple conditions during diagnosis for cardiovascular conditions.

More than half of patients on the epilepsy therapy remained on the treatment after 24 months.

Retrospective analysis suggests that slow vital capacity may have prognostic value when it comes to amyotrophic lateral sclerosis.

Health and Human Services Secretary nominee Alex Azar spoke in front of the Congressional Committee for the first time on Wednesday.

Reddit's Ask Me Anything forums have proven to give physicians a chance to connect with and educate thousands of people at once.

Alex Azar's nomination for secretary of Health and Human Services has been met with controversy due to his ties to the pharmaceutical industry.

5 microRNAs could successfully confirm PCS with 85% accuracy, outperforming the standard patient survey measures of symptom burden.

Medtronic’s Azure XT MRI and Azure S MRI pacemakers improved longevity by 27% compared to available predecessors.

Steve Levine, MD, discussed the challenges physicians must overcome when treating patients with major depressive disorder.

Use of the Lark AI Health Coach resulted in a mean weight loss of 2.38% of baseline weight.

Xtampza showed a reduction in Drug Liking and Take Drug Again Visual Analogue Scale scores for both intact and chewed variations.

The FDA made its decision based on data from a phase 3 trial including more than 200 patients.

Attendees at MS Paris 2017 discussed the biggest unmet needs in treating multiple sclerosis.

The TOPIC study results additionally showed a strong association between CGMV loss and CDMS conversion.

Tanuja Chitnis, MD, spoke about the first-of-its-kind PARADIGMS trial, and pediatric multiple sclerosis, as well as how it differs from the condition in adults.

Subgroup analysis revealed a greater improvement for patients with baseline visual impairment.

Martin Weber, MD, spoke about the role that B cells and antibodies play in the treatment of multiple sclerosis.

The FDA advisory committee voted 16-0 in favor semaglutide's approval.

As COPD exacerbations continue to plague patients, the AIRWISE trial will examine LAMA/LABA/ICS combinations.

The committee voted 10-0 in favor of efficacy and 9-1 in favor of safety.

Pfizer sought 3 indications for its formula, receiving approval for 2 of them, PHN and dDPN.

After multiple roadblocks and a phase 3 trial, the company announced it will not file an NDA for the experimental drug.

The prohibition of cannabis has become a public health issue, according to Doctors for Cannabis Regulation.

Concomitant use of gabapentin and opioids increased the risk of opioid-related death by almost 50%.

The first-of-its-kind approval was based on data from a phase 3 randomized trial involving 484 patients around the world.

In total, 774 cases of nightmares were reported, with 467 of the cases occurring in patients aged 19 years and younger using montelukast.

The drug is being tested for the first time on a large scale adult patient population.

The sc2Wear Infusor allows the opportunity to deliver furosemide subcutaneously and at home, to keep HF patients in need of diuresis out of the hospital.